Email address
[email protected]Contact number
+1 415 268 6237Share profile
Band 3
Provided by Michael R Ward
Patent Strategy + Prosecution, IP Due Diligence, Patent Litigation, Plant Intellectual Property
Michael Ward is global head of the firm’s Life Sciences Industry Group, head of the firm’s Patent Practice Group, co-chair of the firm’s Intellectual Property Practice Group and co-chair of our global Food & Agriculture Industry Group. Dr. Ward is among the foremost figures in the crop protection and plant IP field, developing multibillion dollar, worldwide patent portfolios for some of the world’s most lucrative plant varieties. Clients call on him to lead them through the complex pathway for plant IP protection and perform critical due diligence for potential transactions and licensing deals as well as assess infringement risk. Dr. Ward works closely with a number of clients to develop and manage their patent portfolios. Dr. Ward helps clients to identify, monitor, and assess the infringement risks of third-party patents. He also assists clients in preparing both offensive and defensive patent portfolios, with a particular emphasis on drafting patent applications that will be utilized in licensing and in litigation efforts.
University of California, Berkeley, B.S., 1981; University of California, Davis, M.S., 1984; University of California, Davis, Ph.D., 1988; Golden Gate University School of Law, J.D., 1996
Provided by Chambers
Michael Ward is particularly skilled in agricultural IP matters, frequently advising major clients on patent protection and portfolio development throughout the agricultural sector. He serves as the head of the firm's patent strategy and prosecution practice group.
Provided by Chambers
"Mike Ward has been pivotal in shaping our patent strategy. His profound insight and ability to transform our innovative concepts into patentable assets is commendable."
"Mike Ward has been pivotal in shaping our patent strategy. His profound insight and ability to transform our innovative concepts into patentable assets is commendable."
